Aethlon Medical, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a AEMD research report →
About the company
Aethlon Medical, Inc. operates as a medical technology enterprise, dedicated to innovating solutions for the diagnosis and treatment of life-threatening and organ-jeopardizing diseases within the United States. Central to its pipeline is the Aethlon Hemopurifier, a clinical-stage immunotherapeutic device.
- CEO
- James Frakes
- IPO
- 1999
- Employees
- 14
- HQ
- San Diego, CA, US
Price Chart
- Market Cap
- $540.59K
- P/E
- -0.16
- P/S
- 0.00
- P/B
- 0.23
- EV/EBITDA
- 0.62
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -137.73%
- ROIC
- -139.64%
- Revenue
- $0 · 0.00%
- Net Income
- $-7,151,469 · 46.58%
- EPS
- $-10.61 · 87.63%
- Op Income
- $-7,293,631
- FCF YoY
- -91584056.60%
- 52W High
- $27.40
- 52W Low
- $0.65
- 50D MA
- $1.97
- 200D MA
- $3.25
- Beta
- 1.32
- Avg Volume
- 622.92K
Get TickerSpark's AI analysis on AEMD
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 30, 26 | Shah Chetan | other | 2,182 |
| Jun 30, 26 | Gikakis Nicolas | other | 2,182 |
| Jun 30, 26 | BROENNIMAN EDWARD G | other | 1,091 |
| Apr 17, 26 | Rossetti Angela | other | 21,815 |
| Apr 17, 26 | Shah Chetan | other | 21,815 |
| Apr 17, 26 | BROENNIMAN EDWARD G | other | 21,815 |
| Apr 17, 26 | Gikakis Nicolas | other | 21,815 |
| Mar 31, 26 | Shah Chetan | other | 178 |
| Mar 31, 26 | Gikakis Nicolas | other | 178 |
| Mar 31, 26 | BROENNIMAN EDWARD G | other | 89 |
Our AEMD coverage
Recent articles, reports, and earnings notes.
No research on AEMD yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate AEMD report →Similar companies
Peers in the same neighborhood.